Sep 7, 2011 9:00am EDT Tonix Pharmaceuticals' Bedtime Very Low Dose Cyclobenzaprine Study Featured in Journal of Rheumatology
Jun 20, 2011 9:00am EDT Tonix Pharmaceuticals Elects Harvey Moldofsky, M.D., to its Scientific Advisory Board
Jun 16, 2011 9:00am EDT TONIX Pharmaceuticals Presents Findings on the Effects of Bedtime Very Low Dose (VLD) Cyclobenzaprine (CBP) on Symptoms and Sleep Physiology in Patients with Fibromyalgia Syndrome
Nov 9, 2010 9:00am EST TONIX Pharmaceuticals Reports Analysis of Phase 2a Study of Very Low Dosage Cyclobenzaprine in Fibromyalgia Syndrome (FMS)
